MODAFINIL-BASED TREATMENT FOR PREMATURE EJACULATION

(19)

(11)

EP 2 056 811 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	21.03.2018 Bulletin 2018/12

(45)	Mention of the grant of the patent:
	07.02.2018 Bulletin 2018/06

(21)	Application number: 07811305.7

(22)	Date of filing: 13.08.2007

(51)

International Patent Classification (IPC):

A61K 31/165^(2006.01)

A61P 15/00^(2006.01)

(86)	International application number:
	PCT/US2007/017948

(87)	International publication number:
	WO 2008/021341 (21.02.2008 Gazette 2008/08)

(54)	MODAFINIL-BASED TREATMENT FOR PREMATURE EJACULATION BEHANDLUNG AUF MODAFINILBASIS GEGEN VORZEITIGE EJAKULATION TRAITEMENT À BASE DE MODAFINIL CONTRE L'ÉJACULATION PRÉCOCE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

14.08.2006 US 837474 P

(43)	Date of publication of application:
	13.05.2009 Bulletin 2009/20

(73)	Proprietor: NeuroHealing Pharmaceuticals, Inc.
	Newton, MA 02135 (US)

(72)	Inventor:
	KATZMAN, Daniel, E. Newton, MA 02135 (US)

(74)	Representative: Abel & Imray
	Westpoint Building James Street West Bath BA1 2DA Bath BA1 2DA (GB)

(56)

References cited: :

EP-A- 1 291 016
WO-A-2006/032146

WO-A-02/30413
US-A1- 2003 034 373

WALDINGER M D: "USE OF PSYCHOACTIVE AGENTS IN THE TREATMENT OF SEXUAL DYSFUNCTION" CNS DRUGS, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 6, no. 3, 1 September 1996 (1996-09-01), pages 204-216, XP000972593 ISSN: 1172-7047
MARSON L ET AL: "EFFECTS OF NH02D ON EJACULATION LATENCY AND SEXUAL BEHAVIOR IN RATS" JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 181, no. 4, 1 April 2009 (2009-04-01), page 241, XP026008735 ISSN: 0022-5347 [retrieved on 2009-03-18]
LESLEY MARSON, GUOZHONG YU, AND NEAL M. FARBER,: "The Effects of Oral Administration of D-Modafinil on Male Rat Ejaculatory Behavior" JOURNAL OF SEXUAL MEDICINE, 2009, pages 1-9, XP002554043

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).